Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-02 @ 7:43 AM
Study NCT ID:
NCT00490594
Status:
UNKNOWN
Last Update Posted:
2008-10-20
First Post:
2007-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D007718', 'term': 'Knee Injuries'}, {'id': 'D000070598', 'term': 'Anterior Cruciate Ligament Injuries'}], 'ancestors': [{'id': 'D007869', 'term': 'Leg Injuries'}, {'id': 'D014947', 'term': 'Wounds and Injuries'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 30}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2007-06'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2008-10', 'lastUpdateSubmitDate': '2008-10-17', 'studyFirstSubmitDate': '2007-06-20', 'studyFirstSubmitQcDate': '2007-06-21', 'lastUpdatePostDateStruct': {'date': '2008-10-20', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2007-06-22', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2008-10', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Safety - measured by device related SAEs', 'timeFrame': '12 months'}, {'measure': 'KT-1000 Arthrometer', 'timeFrame': '12 months'}], 'secondaryOutcomes': [{'measure': 'Knee Surveys', 'timeFrame': '12 months'}, {'measure': 'Return to Work', 'timeFrame': '12 months'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['ACL', 'ligament', 'ACL injury'], 'conditions': ['Anterior Cruciate Ligament', 'Knee Injuries']}, 'descriptionModule': {'briefSummary': "The SeriACL device was developed as an alternative to an autograft (i.e., tissue that is taken from a patient's own body) or an allograft (i.e., tissue that is taken from a cadaver) for ACL reconstruction. The SeriACL device is made of silk yarns, knit and processed with SeriCoat™ surface treatment which makes it easier to wet the material. The SeriACL device is designed to be a temporary support structure to replace the torn ACL and to stabilize the knee joint following surgical repair. It is designed to use the body's own healing process to regenerate the patient's own new ligament tissue. As the new tissue grows and the support structure is needed less over time, the SeriACL device is bioresorbed (i.e., broken down) by the patient's body. The SeriACL device is designed to be installed with standard surgical techniques for ACL repair.\n\nThis study is designed to test the safety of the SeriACL device in primary total ACL repair in patients with a torn ACL. The study will evaluate whether repair of the ACL with the SeriACL device will return the knee to normal function and what, if any, side effects will occur."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '45 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Complete ACL rupture\n* Injured knee range of motion \\>= 75% of contralateral knee\n* MCL tear grading \\<= 2\n* Sign informed consent.\n\nExclusion criteria:\n\n* Prior ACL reconstruction\n* Complete PCL tear\n* Locked bucket handle tear or complex tears of the menisci.\n* Contralateral knee ligament injury\n* Known joint disease\n* Known allergy to silk\n* Active drug or alcohol abuse\n* Pregnant'}, 'identificationModule': {'nctId': 'NCT00490594', 'briefTitle': 'SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction', 'organization': {'class': 'INDUSTRY', 'fullName': 'Serica Technologies, Inc.'}, 'officialTitle': 'A Multi-Center Open Study to Evaluate the SeriACL™ Device for Primary Anterior Cruciate Ligament Repair', 'orgStudyIdInfo': {'id': 'CLN-ACL1'}}, 'armsInterventionsModule': {'interventions': [{'name': 'ACL Reconstruction (SeriACL™ Device)', 'type': 'DEVICE', 'description': 'Bioresorbable ACL'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Heidelberg', 'country': 'Germany', 'facility': 'Atos Clinic', 'geoPoint': {'lat': 49.40768, 'lon': 8.69079}}, {'city': 'Heidelberg', 'country': 'Germany', 'facility': 'Heidelberg University', 'geoPoint': {'lat': 49.40768, 'lon': 8.69079}}, {'city': 'Oslo', 'country': 'Norway', 'facility': 'Ullevaal Hospital', 'geoPoint': {'lat': 59.91273, 'lon': 10.74609}}], 'overallOfficials': [{'name': 'Lars Engebretsen, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Ullevaal Hospital'}, {'name': 'Hans Paessler, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'ATOS Clinic, Heidelberg'}, {'name': 'Holger Schmitt, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Heidelberg University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Serica Technologies, Inc.', 'class': 'INDUSTRY'}, 'responsibleParty': {'oldNameTitle': 'Rebecca Horan', 'oldOrganization': 'Serica Technologies, Inc.'}}}}